Skip to main content
Novartis
language-selector-globe
Choose location
language-selector-globeCanada | en
EnglishFrançais
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Albania | English
Albania | Shqip
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose location
language-selector-globeCanada
EnglishFrançais
Americas Asia Pacific Europe International Middle East & Africa
Albania | English
Albania | Shqip
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in Canada 
      • Diversity, Equity and Inclusion 
      • Executive Committee 
      • People and Culture 
      • Therapeutic Areas 
      • Products 
      • Our people Stories 
      • Contact Us 
      Novartis office
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Patient perspective Stories 
      Patients and Caregivers
      Patients and Caregivers
    • Healthcare Professionals 
      • HCP Portal 
      • Products 
      • Pipeline (EN) 
      • Adverse Event Reporting 
      • Clinical Trials 
      • Novartis Clinical Trials 
      • Disclosure Of Payments To Healthcare Professionals 
      Healthcare Professionals Header Image
      Healthcare Professionals
    • ESG 
      • Access 
      • Ethics, Risk and Compliance 
      • Grants and Donations 
      • Health Equity Initiative 
        • Guidelines and Eligibility Criteria 
        • About the Novartis Health Equity Initiative 
      • Corporate Responsibility 
        • AODA Compliant - EN (PDF 0.2 MB) 
        • AODA Compliant - FR (PDF 0.2 MB) 
        • AMA Compliant - EN (PDF 0.2 MB) 
        • AMA Compliant - FR (PDF 0.2 MB)  
        • Disclosure Of Payments To Healthcare Professionals 
        • Environmental Sustainability 
      • Reporting and Transparency Hub 
      • Human Rights 
      Environment, Society and Governance
      ESG
    • News 
      • News Archive 
      • Our people Stories 
      • Website Privacy Policy 
      • General Privacy Notice for Business Partners 
      • General Privacy Notice for Third Parties 
      • General Privacy Notice for External Stakeholders 
      • Privacy Notice for Pharmacovigilance, Medical Information, and Product Quality Complaints 
    • Careers 
      • Diversity, Equity and Inclusion 
      • People and Culture 
      • Career Search 
      • How We Work 
      • Well-being 
      Two women chatting
      Careers
    • Contact Us 
    Office call pods
    Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
扬帆医药代表(MR Intern) Lishui (Zhejiang Province) China International Sales Others Jun 02, 2026
Manager, BR Clinical Quality Assurance Shanghai (Shanghai) China Biomedical Research Research Quality May 28, 2026
Head of China C&BD Shanghai (Shanghai) China Strategy & Growth Strategic Planning & BD&L BD&L & Strategic Planning May 26, 2026
Sr. Specialist DDIT OPS Site Automation Expert Haiyan (Zhejiang Province) China Operations Information Technology Information Technology May 25, 2026
扬帆医药代表(MR Intern) Nanning (Guangxi Province) China International Sales Others May 21, 2026
扬帆医药代表(MR Intern) Panzhihua (Sichuan Province) China International Sales Others May 17, 2026
扬帆医药代表(MR Intern) Beijing (Beijing) China International Sales Others May 17, 2026
扬帆医药代表(MR Intern) Shanghai (Shanghai) China International Sales Others May 17, 2026
扬帆医药代表(MR Intern) Wuhan (Hubei Province) China International Sales Others May 11, 2026
扬帆医药代表(MR Intern) Beijing (Beijing) China International Sales Others May 11, 2026
扬帆医药代表(MR Intern) Jinan (Shandong Province) China International Sales Others May 11, 2026
Head, TCO (Translational Clinical Oncology) China Shanghai (Shanghai) China Biomedical Research Research Research & Development Apr 28, 2026
Associate Director, TPPM Shanghai (Shanghai) China Development Development Research & Development Apr 16, 2026
Medical Science Liaison -IMMU Shenyang (Liaoning Province) China International Development Research & Development Apr 15, 2026
Associate Director, Quality Evaluations, Integrations, and External Services Shanghai (Shanghai) China Biomedical Research Research Quality Apr 13, 2026
Associate Director, CMC Competitive Intelligence Management Shanghai (Shanghai) China Development Development Research & Development Apr 08, 2026
Brand Manager, IPA Shanghai (Shanghai) China International General Management Marketing Feb 06, 2026
Senior Project Engineer(Manager Level) Changping County (Beijing) China Operations Production / Manufacturing Technical Operations Jan 04, 2026

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • › Next page
No matching countries found
Search

Novartis Canada

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Other Novartis Websites
  • Global site
  • HCP Portal
Footer Bottom
© 2026 Novartis AG
  • Terms of Use
  • Privacy
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in Canada.